Cargando…
Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins
Apolipoprotein E4 (apoE4), the leading genetic risk factor for Alzheimer's disease (AD), is less lipidated compared to the most common and AD-benign allele, apoE3. We have recently shown that i.p. injections of the ATP-binding cassette A1 (ABCA1) agonist peptide CS-6253 to apoE mice reverse the...
Autores principales: | Boehm-Cagan, Anat, Bar, Roni, Harats, Dror, Shaish, Aviv, Levkovitz, Hana, Bielicki, John K., Johansson, Jan O., Michaelson, Daniel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100931/ https://www.ncbi.nlm.nih.gov/pubmed/27824936 http://dx.doi.org/10.1371/journal.pone.0166195 |
Ejemplares similares
-
ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice
por: Liraz, Ori, et al.
Publicado: (2013) -
Prevention of Atherosclerosis Progression by 9-cis-β-Carotene Rich Alga Dunaliella in apoE-Deficient Mice
por: Harari, Ayelet, et al.
Publicado: (2013) -
The effects of apolipoprotein E genotype, α-synuclein deficiency, and sex on brain synaptic and Alzheimer's disease–related pathology
por: Bar, Roni, et al.
Publicado: (2017) -
Omapatrilat, an Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitor, Attenuates Early Atherosclerosis in Diabetic and in Nondiabetic Low-Density Lipoprotein Receptor–Deficient Mice
por: Levy, Zohar, et al.
Publicado: (2003) -
Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?
por: Bitzur, Rafael, et al.
Publicado: (2009)